Macrophages in renal inflammation

Current Opinion in Nephrology and Hypertension

Volumn 10, Issue 3, 2001, Pages 341-347

  Erwig, Lars Peter ^a   Kluth, David C ^a   Rees, Andrew J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION; CELL FUNCTION; DISEASE COURSE; GENE THERAPY; GLOMERULUS EPITHELIUM; HUMAN; MACROPHAGE; MACROPHAGE ACTIVATION; NEPHRITIS; PRIORITY JOURNAL; REVIEW;

HUMANS; INFLAMMATION; KIDNEY DISEASES; MACROPHAGE ACTIVATION; MACROPHAGES;

EID: 0035017336     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200105000-00007     Document Type: Review

References (56)

1. Immunologic renal diseases
2. Macrophages in acute glomerular inflammation
3. Modulation of macrophage function by transforming growth factor- beta, interleukin-4 and interleukin-10
4. Role of leukocytes and endothelial cells in the development of angiogenesis in inflammation and wound healing
5. Modulation of macrophage maturation by cytokines and lipid mediators: A potential role in resolution of pulmonary inflammation
6. Local macrophage proliferation in human glomerulonephritis
7. Expression of the C-C chemokine receptor 5 in human kidney diseases
8. Glomerular monocyte-macrophage features in ANCA-positive renal vasculitis and cryoglobulinemic nephritis
9. Other functions, other genes: Alternative activation of antigen-presenting cells
10. Macrophage-restricted molecules: Role in differentiation and activation
11. Immune inhibitory receptors
12. Signalling heterogeneity as a contributing factor in macrophage functional diversity
13. Initial cytokine exposure determines macrophage function and renders them unresponsive to other cytokines
14. Previous uptake of apoptotic neutrophils or ligation of integrin receptors downmodulates the ability of macrophages to ingest apoptotic neutrophils
15. Macrophages from inflamed but not normal glomeruli are unresponsive to anti-inflammatory cytokines
16. Leukocyte recruitment and the acute inflammatory response
17. Varying roles of E-selectin and P-selectin in different microvascular beds in response to antigen
18. Antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 prevent glomerular injury in rat experimental crescentic glomerulonephritis
19. Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis
20. Attenuation of immune-mediated glomerulonephritis with an anti-CD11b monoclonal antibody
21. Differing roles of CD18 and VLA-4 in leukocyte migration/activation during anti-GBM nephritis
22. Endothelial expression of VCAM-1 in experimental crescentic nephritis and effect of antibodies to very late antigen-4 or VCAM-1 on glomerular injury
23. Combinatorial model of chemokine involvement in glomerular monocyte infiltration
24. Macrophage trafficking to inflamed glomeruli: A novel system of analysis
25. A new class of membrane-bound chemokine with a CX3C motif
26. In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II
27. Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1
28. C-C and C-X-C chemokines trigger firm adhesion of monocytes to vascular endothelium under flow conditions
29. Monocyte chemoattractant protein 1 mediates glomerular macrophage infiltration in anti-GBM Ab GN
30. Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis
31. Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(Ipr) mice
32. MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis
33. Chemokine blockade as a therapy for renal disease
34. Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis
35. Increased severity of glomerulonephritis in C-C chemokine receptor 2 knockout mice
36. New approaches to modify glomerular inflammation
37. Interleukin-4 deficiency enhances Th1 responses and crescentic glomerulonephritis in mice
38. Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis
39. Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis
40. Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats
41. MIP-1alpha as a critical macrophage chemoattractant in murine wound repair
42. Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression
43. Transforming growth factor-beta isoforms and glomerular injury in nephrotoxic nephritis
44. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases
45. Gene therapy for established murine collagen-induced athritis by local and systemic adenovirus-mediated delivery of interleukin-4
46. Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees
47. Strategies for gene transfer to the kidney
48. Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis
49. Novel approaches to treatment of glomerulonephritis
50. Signal transduction through NF-kappa B
51. Multiple signals converging on NF-kB
52. In vivo administration of a nuclear transcription factor-kappaB decoy suppresses experimental crescentic glomerulonephritis
53. Gene transfer into inflamed glomeruli using macrophages transfected with adenovirus
54. Inflamed site specific gene delivery using bone marrow derived CD11b+ CD18+ vehicle cells in mice
55. Prophylaxis of antibody-induced acute glomerulonephritis with genetically modified bone marrow-derived vehicle cells
56. Macrophages transfected with adenovirus to express IL-4 reduce inflammation in experimental glomerulonephritis